Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-151
Closed -$1K 471
2022
Q2
$1K Buy
+151
New +$953 ﹤0.01% 1121
2021
Q4
Sell
-152
Closed -$1K 351
2021
Q3
$1K Sell
152
-3
-2% -$21 ﹤0.01% 927
2021
Q2
$1K Buy
155
+14
+10% +$96 ﹤0.01% 925
2021
Q1
$1K Buy
141
+8
+6% +$41 ﹤0.01% 847
2020
Q4
$1K Sell
133
-377
-74% -$1.67K ﹤0.01% 838
2020
Q3
$2K Buy
510
+360
+240% +$1.75K ﹤0.01% 796
2020
Q2
$1K Sell
150
-225
-60% -$1.11K ﹤0.01% 783
2020
Q1
$2K Buy
375
+52
+16% +$333 ﹤0.01% 649
2019
Q4
$2K Hold
323
﹤0.01% 654
2019
Q3
$2K Buy
323
+30
+10% +$203 ﹤0.01% 713
2019
Q2
$2K Buy
293
+45
+18% +$301 ﹤0.01% 735
2019
Q1
$2K Buy
+248
New +$1.6K ﹤0.01% 667

Other funds holding AIV

CX Institutional's AIV Position: Q3 2022 in Review

CX Institutional sold out of Aimco (AIV) in Q3 2022, closing a stake of 151 shares — an estimated $1K sold.

CX Institutional first reported a position in AIV in Q1 2019 and held it in 12 quarters. The position peaked at $2K in Q3 2020. 197 funds tracked by Wall St. Rank hold AIV as of Q3 2022.

  • CX Institutional reported no remaining Aimco position as of Q3 2022 after selling out during the quarter.
  • CX Institutional sold 151 Aimco shares in Q3 2022, an estimated $1K.
  • CX Institutional first reported a position in Aimco in Q1 2019 and held it in 12 quarters.
  • CX Institutional's Aimco position peaked at $2K in Q3 2020.
  • 197 funds tracked by Wall St. Rank held Aimco as of Q3 2022.

Based on CX Institutional's 13F filing for Q3 2022, filed 4 Nov 2022.